Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies.

MLA

Tamariz-Amador, Luis-Esteban, et al. “Immune Biomarkers to Predict SARS-CoV-2 Vaccine Effectiveness in Patients with Hematological Malignancies.” Blood Cancer Journal, vol. 11, no. 12, Dec. 2021, p. 202. EBSCOhost, https://doi.org/10.1038/s41408-021-00594-1.

APA

Tamariz-Amador, L.-E., Battaglia, A. M., Maia, C., Zherniakova, A., Guerrero, C., Zabaleta, A., Burgos, L., Botta, C., Fortuño, M.-A., Grande, C., Manubens, A., Arguiñano, J.-M., Gomez, C., Perez-Persona, E., Olazabal, I., Oiartzabal, I., Panizo, C., Prosper, F., San-Miguel, J. F., … Paiva, B. (2021). Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies. Blood Cancer Journal, 11(12), 202. https://doi.org/10.1038/s41408-021-00594-1

Chicago

Tamariz-Amador, Luis-Esteban, Anna Martina Battaglia, Catarina Maia, Anastasiia Zherniakova, Camila Guerrero, Aintzane Zabaleta, Leire Burgos, et al. 2021. “Immune Biomarkers to Predict SARS-CoV-2 Vaccine Effectiveness in Patients with Hematological Malignancies.” Blood Cancer Journal 11 (12): 202. doi:10.1038/s41408-021-00594-1.